Eur J Med Chem 184:111753
Patients should understand that while the medication itself won't show up on blood tests, the therapeutic effects of GLP-1 drugs are clearly evident through improved metabolic markers: lower HbA1c, reduced fasting glucose, potential improvements in lipid profiles, and weight loss
A 2025 systematic review and meta-analysis in Obesity Reviews found that significant weight is regained after GLP-1 receptor agonist treatment is discontinued, which supports the need for continuity planning before therapy ends [5]
Specifically air injection during bacteriostatic water addition
a mild stinging sensation may occur due to the quinolinium structure
Pharmacological inhibition of HDAC by VPA restored histone H3 acetylation levels, reversed synaptic plasticity aberrations and improved the epileptic phenotype in TSC2 +/ mice